Nicolas Meneveau

Nicolas Meneveau

Interventional cardiologist

Regional University Hospital Jean Minjoz, Besancon, France

  • Radcliffe

Media

ESC 2019 - Changes to ESC Guidelines for High-Risk Pulmonary Embolism Patients

Nicolas Meneveau

Watch time: 1m 19s
ESC 2018: Rationale For New Treatment Options For Intermediate

Nicolas Meneveau, Andrew SP Sharp, Adriaan Kraaijeveld, et al

Watch time: 14m 32s
ESC 2018: Rationale For New Treatment Options For Intermediate-High Risk PE Patients

Andrew SP Sharp, Adriaan Kraaijeveld, Nicolas Meneveau, et al

Watch time: 14m 32s
ESC 2018: Rationale For New Treatment Options For Intermediate-High Risk PE Patients

Nicolas Meneveau, Andrew SP Sharp, Adriaan Kraaijeveld, et al

Watch time: 14m 32s
ESC 2018: Rationale For New Treatment Options For Intermediate-High Risk PE Patients

Nicolas Meneveau, Andrew SP Sharp, Adriaan Kraaijeveld, et al

Watch time: 14m 32s
New Treatment Options For Intermediate-High Risk PE

Nicolas Meneveau, Andrew SP Sharp, Adriaan Kraaijeveld, et al

Watch time: 27m 16s
ESC 2018: Rationale for New Treatment Options for Intermediate-High Risk PE Patients

Nicolas Meneveau, Andrew SP Sharp, Adriaan Kraaijeveld, et al

Watch time: 19m 4s
ESC 2018: New Treatment Options - High Risk PE Patients

Nicolas Meneveau, Adriaan Kraaijeveld, , et al

Watch time: 14m 32s
ESC 2018: Rationale For New Treatment Options For Intermediate-High Risk PE Patients

Nicolas Meneveau, Adriaan Kraaijeveld, , et al

Watch time: 5m 49s
ESC 2018: Rationale for new treatment options for intermediate-high risk PE patients

Nicolas Meneveau, Adriaan Kraaijeveld, , et al

Watch time: 19m 4s
ESC 2018: Acoustic Pulse Thrombolysis™ Treatment For Pulmonary Embolism Patients: Rationale, Experience And Data

Adriaan Kraaijeveld, Nicolas Meneveau, , et al

Watch time: 5m 49s
Symposium at ESC Congress 2018 sponsored by EKOS Corporation

Nicolas Meneveau, Andrew SP Sharp, Adriaan Kraaijeveld, et al

Watch time: 5m 49s